MBX Biosciences Common Stock Overview
MBX Biosciences Common Stock Target Price
Analysts' 12-month price predictions for MBX.
Get informed when a big investor buys or sells
+ FollowShare Price
$30.05
Average Target Price
$61.50
104.7% upside
104.7% upside4 analysts in the last 4 months
High: $70 | Low: $50
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-05-12 | Stifel Nicolaus | $56 | 86.4% upside |  |
| 2026-05-12 | Barclays | $70 | 132.9% upside | |
| 2026-05-11 | Truist FinancialSrikripa Devarakonda | $70 | 132.9% upside | |
| 2026-03-09 | Truist FinancialSrikripa Devarakonda | $50 | 66.4% upside | |
| 2026-01-27 | Barclays | $66 | 119.6% upside | |
| 2026-01-16 | GuggenheimSeamus Fernandez | $88 | 192.8% upside | |
| 2026-01-07 | UBSMichael Yee | $60 | 99.7% upside | |
| 2025-12-19 | Stifel NicolausAnnabel Samimy | $50 | 66.4% upside | |
| 2025-12-04 | Goldman Sachs | $18 |  40.1% downside | |
| 2025-08-05 | Mizuho Securities | $38 | 26.5% upside | |
| 2024-10-08 | GuggenheimSeamus Fernandez | $44 | 46.4% upside | |